NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 177 filers reported holding NEKTAR THERAPEUTICS in Q1 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $449,000 | -71.3% | 36,604 | -59.8% | 0.00% | -72.7% |
| Q3 2016 | $1,562,000 | +7.9% | 90,961 | -10.5% | 0.01% | 0.0% |
| Q2 2016 | $1,447,000 | +143.2% | 101,685 | +135.1% | 0.01% | +120.0% |
| Q1 2016 | $595,000 | -54.4% | 43,245 | -44.1% | 0.01% | +25.0% |
| Q4 2015 | $1,304,000 | -57.4% | 77,400 | -72.3% | 0.00% | -76.5% |
| Q3 2015 | $3,060,000 | +0.8% | 279,197 | +15.0% | 0.02% | -5.6% |
| Q2 2015 | $3,036,000 | +76.7% | 242,715 | +55.4% | 0.02% | +38.5% |
| Q1 2015 | $1,718,000 | +283.5% | 156,200 | +264.1% | 0.01% | +1200.0% |
| Q3 2013 | $448,000 | – | 42,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
| First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
| BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
| Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
| BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
| Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
| Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
| Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
| TOBAM | 640,547 | $21,522,000 | 1.09% |
| Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |